AnalystsYi ChenYi Chen's Stock Forecasts
AnalystsYi Chen
Analyst Ranking
Top 1%
#36 out of 3846 analysts
Average Return
+25.91%
Win Rate
51%50 out of 98
Risk vs Reward
Poor
Good
Yi Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Htg Molecular Diagnostics IncHTGM | +1,622.56% | $0.33 | $5.65 | 2020-03-26 - 2021-03-26 | Buy |
Sensus Healthcare IncSRTS | +301.93% | $3.62 | $14.55 | 2021-08-06 - 2022-08-05 | Buy |
Ocular Therapeutix IncOCUL | +267.37% | $5.21 | $19.14 | 2020-02-10 - 2021-02-10 | Buy |
Applied Dna Sciences IncAPDN | +250.00% | $1.42 | $4.97 | 2022-05-16 - 2022-08-09 | Buy |
Sensus Healthcare IncSRTS | +232.69% | $4.13 | $13.74 | 2021-11-05 - 2022-08-09 | Buy |
Yi Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Applied Dna Sciences IncAPDN | 5 | Buy | $8.00 | +60.97% | Maintains | 3 days ago |
Eyepoint Pharmaceuticals IncEYPT | 3 | Buy | $25.00 | +131.05% | Maintains | 7 days ago |
Belite Bio IncBLTE | 1 | Buy | $58.00 | +105.53% | Initiates Coverage On | 10 days ago |
Alimera Sciences IncALIM | 6 | Buy | $9.00 | +32.74% | Maintains | 14 days ago |
Kiora Pharmaceuticals IncKPRX | 3 | Buy | $2.50 | +1,523.38% | Maintains | a month ago |
Meridian Bioscience IncVIVO | 7 | Hold | $34.00 | +4.39% | Downgrades | a month ago |
Renalytix PLCRNLX | 2 | Buy | $15.00 | +502.41% | Maintains | a month ago |
Mainz Biomed NvMYNZ | 1 | Buy | $25.00 | +169.69% | Initiates Coverage On | 2 months ago |
Kala Pharmaceuticals IncKALA | 6 | Buy | $4.00 | +1,115.81% | Maintains | 3 months ago |
Stealth Biotherapeutics CorpMITO | 3 | Buy | $1.50 | +388.60% | Maintains | 3 months ago |
Bio Path Holdings IncBPTH | 1 | Buy | $9.00 | +127.85% | Maintains | 3 months ago |
Prophase Labs IncPRPH | 4 | Buy | $14.00 | +29.15% | Maintains | 3 months ago |
Co Diagnostics IncCODX | 3 | Buy | $12.00 | +89.57% | Maintains | 3 months ago |
Htg Molecular Diagnostics IncHTGM | 4 | Buy | $3.00 | +167.86% | Maintains | 3 months ago |
Motus Gi Holdings IncMOTS | 2 | Buy | $1.50 | -59.02% | Maintains | 3 months ago |
Opgen IncOPGN | 1 | Buy | $3.00 | +417.24% | Maintains | 3 months ago |
Ocular Therapeutix IncOCUL | 5 | Buy | $10.00 | +103.67% | Maintains | 3 months ago |
Sensus Healthcare IncSRTS | 7 | Buy | $16.00 | +16.45% | Maintains | 3 months ago |
Dentsply Sirona IncXRAY | 5 | Hold | $48.00 | +32.19% | Maintains | 4 months ago |
Veru IncVERU | 5 | Buy | $24.00 | +108.70% | Maintains | 4 months ago |
Nemaura Medical IncNMRD | 1 | Buy | $12.00 | +433.33% | Initiates Coverage On | 4 months ago |
Zynex IncZYXI | 6 | Buy | $20.00 | +112.09% | Maintains | 6 months ago |
Ortho Clinical Diagnostics Holdings PLCOCDX | 3 | Hold | $24.68 | +39.99% | Downgrades | 7 months ago |
Vaccitech PLCVACC | 2 | Buy | $23.00 | +360.92% | Maintains | 8 months ago |
Interpace Biosciences IncIDXG | 4 | Hold | N/A | N/A | Downgrades | 9 months ago |
Greenwich Lifesciences IncGLSI | 1 | Buy | $78.00 | +798.62% | Initiates Coverage On | a year ago |
Check Cap LtdCHEK | 2 | Buy | $3.00 | N/A | Maintains | a year ago |
First Wave Biopharma IncFWBI | 4 | Buy | $2.00 | N/A | Maintains | a year ago |
Clearside Biomedical IncCLSD | 1 | Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Anixa Biosciences IncANIX | 1 | Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Eyenovia IncEYEN | 2 | Buy | $8.00 | N/A | Maintains | a year ago |
Aslan Pharmaceuticals LtdASLN | 2 | Buy | $8.00 | N/A | Maintains | a year ago |
Celcuity IncCELC | 2 | Buy | $19.00 | N/A | Maintains | a year ago |
Caredx IncCDNA | 1 | Buy | $45.00 | N/A | Maintains | 2 years ago |
Cytodyn IncCYDY | 2 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Oragenics IncOGEN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.